Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKesson
Moodys
Express Scripts
Fish and Richardson
Teva
Argus Health
Deloitte
Fuji
Healthtrust

Generated: October 20, 2017

DrugPatentWatch Database Preview

MAXZIDE Drug Profile

« Back to Dashboard

Which patents cover Maxzide, and what generic Maxzide alternatives are available?

Maxzide is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in MAXZIDE is hydrochlorothiazide; triamterene. There are thirty-one drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.

Summary for Tradename: MAXZIDE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Bulk Api Vendors: see list77
Clinical Trials: see list1
Patent Applications: see list32
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MAXZIDE at DailyMed

Pharmacology for Tradename: MAXZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
MAXZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL019129-001Oct 22, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
MAXZIDE-25
hydrochlorothiazide; triamterene
TABLET;ORAL019129-003May 13, 1988ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MAXZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
MAXZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL019129-001Oct 22, 1984► Subscribe► Subscribe
Mylan Pharms Inc
MAXZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL019129-001Oct 22, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Chubb
UBS
Accenture
Julphar
Mallinckrodt
McKesson
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot